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Background: Retinal implants have been developed to treat blindness causing
retinal degenerations such as Retinitis pigmentosa (RP). The retinal stimulators are
covering only a small portion of the retina usually in its center. To restore not only
central vision but also a useful visual field retinal stimulators need to cover a larger
area of the retina. However, large area retinal stimulators are much more difficult to
implant into an eye. Some basic questions concerning this challenge should be
answered in a series of experiments.
Methods: Large area retinal stimulators were fabricated as flexible multielectrode
arrays (MEAs) using silicon technology with polyimide as the basic material for the
substrate. Electrodes were made of gold covered with reactively sputtered iridium
oxide. Several prototype designs were considered and implanted into enucleated
porcine eyes. The prototype MEAs were also used as recording devices.
Results: Large area retinal stimulator MEAs were fabricated with a diameter of
12 mm covering a visual angle of 37.6° in a normal sighted human eye. The
structures were flexible enough to be implanted in a folded state through an
insertion nozzle. The implants could be positioned onto the retinal surface and
fixated here using a retinal tack. Recording of spontaneous activity of retinal neurons
was possible in vitro using these devices.
Conclusions: Large flexible MEAs covering a wider area of the retina as current devices
could be fabricated using silicon technology with polyimide as a base material. Principal
surgical techniques were established to insert such large devices into an eye and the
devices could also be used for recording of retinal neural activity.
Keywords: Retinal prosthesis, Artificial vision, Retinitis pigmentosa, Blindness,
Rehabilitation, Vitreoretinal surgery, Silicon wafer Technology, Polyimide, NeurostimulationBackground
Retinal degenerations such as Retinitis pigmentosa (RP) may cause bilateral blindness.
It is estimated that in Germany about 15,000 subjects are legally blind due to this dis-
ease. Although it is known that the disease is caused by a variety of mutations in se-
veral genes coding for key enzymes involved in retinal metabolism and light processing
[1–3] no treatment is really established. Since it has been demonstrated that blind RP
subjects were able to detect light spots and patterns by electrical stimulation of the re-
tina [4–6] visual prostheses have been fabricated, approved, and used in RP patients© 2014 Waschkowski et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
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neath the retina or onto the retinal surface and a system for signal and energy transfer
[11–13]. Up to now stimulating electrode arrays were designed as very small devices
for stimulation of the fovea and the perifoveal region (Table 1). However, small devices
are not capable to restore a large visual field, because they simply contact only a small
area of the retina, e.g. 5 × 5 mm as for the ARGUS II device representing a visual angle
of about 18° (or 9° visual field respectively) in a normal sized eye. For blind RP patients
the re-activation of a large visual field is important to regain mobility and orientation.
Therefore we conducted experiments in fabrication and handling to evaluate whether it
is possible to build stimulators for large retinal areas. The challenge was that such large
structures must have the flexibility to be inserted through a small incision into the eye
without damage of the delicate electronic structures or the eye itself.
Methods
Simulation of material characteristics
To get an idea of the behavior of a polyimide foil within an eye, we created a very sim-
ple model for Comsol, a common finite element simulation software. The model con-
sists of an incompressible spherical shell made of steel with an inner diameter of
22 mm and a polyimide foil with a thickness of 100 μm, a disc shape and a circular hole
in the center of the structure. Then the foil was vertically moved into the shell until
both parts came into contact. The Young’s modulus of the polyimide PI2611 we used
in this simulation was 8.5 GPa and was taken from the material data sheet, the poisson
ratio of 0.23 was taken from Patel et al. [14]. The friction between the polyimide foil
and the shell was disregarded.
Fabrication process
Fabrication of the stimulator prototypes takes place on silicon wafers as described in
detail in Figure 1. First, wafers are metalized with an aluminium sacrificial layer (1 μm)
and with titanium adhesion layers underneath (50 nm) and on top (150 nm). Then a
first layer of polyimide PI2611 is deposited by spincoating with a thickness of 5 μm. It
is structured by a wet etching process and baked at 400°C under nitrogen atmosphere
for 3 hours to polymerize. Now the conducting paths, the electrodes and the contact
pads are built by electroplating of gold onto the polyimide with a thickness of 2.5 μm.
A chromium layer of 30 nm thickness serves as an adhesion layer. For non-electrically
functional test devices we created a fake-wiring to get similar mechanical characteris-
tics as the final electrically functional stimulators and to improve the visibility of the
structures during surgery. We also tried to find the optimal positioning of theTable 1 Overview on known sizes (width/height/thickness) of electrode arrays used in
retina implants with direct retinal contact and their respective number of electrodes
Implant Concept # of electrodes Dimensions (w/h/t in mm)
Retinal implant AG Subretinal 1500 3/3/0.07*)
Argus II second sight Epiretinal 60 5/5/0.5**)
EPIRET III Epiretinal 25 2/3/0.02 [8]
*)E. Zrenner, et al. Visual Sensations Mediated By Subretinal Microelectrode Arrays Implanted into Blind Retinitis
Pigmentosa Patients. Proc. 13th Annu. Conf. of the IFESS, Freiburg, 2008.
**)V. Kandagor, et al. In situ Characterization of Stimulating Microelectrode Arrays: Study of an Idealized Structure Based
on Argus II Retinal implants. Implantable Neural Prostheses, Springer New York; 2010. pp. 139-56.
a)  b) 
c)  d) 
Figure 1 Fabrication process of VLARS prototypes. a) 5 μm of polyimide spincoated and structured on
Si-Wafer with sacrificial Al-layer (black), b) 2.5 μm of electroplated gold for wiring, c) another 5 μm of
polyimide for isolation and protection of the wiring, d) after opening the second PI layer the electrodes are
formed by another electroplating step. Further steps include: iridium oxide is sputtered and structured with
a lift-off process, and the surface is coated with Parylene C, the electrodes are opened by a dry-etching
process with oxygen plasma. Afterwards the devices are separated by etching the sacrificial Al-layer.
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of the wiring to encapsulate the gold layer. For the second generation of dummy struc-
tures we added a Parylene C layer, which will be used in the final devices for additional
isolation and protection against moisture. It is deposited onto the devices by a CVD
process with a final thickness of 3 μm and patterned by a dry-etching process with
oxygen plasma. The thicknesses of all layers were chosen as in the fabrication of the
EPI-RET III implant [15]. The electrodes of the final devices are formed by a second
electroplating step after structuring the second PI-layer and are coated with reactively
sputtered iridium oxide films with a thickness of 500 nm. That leads, due to its high
charge delivery capacity, to low electrode impedance which allows the use of low stimu-
lation voltages [15]. Low voltages could increase the durability of the electrodes during
long term stimulation experiments. The resulting devices were labeled as VLARS MEA
(very large area retinal stimulator - multielectrode array).
Simulation of the surgical approach
The surgical approach was simulated by performing the procedure in enucleated por-
cine eyes. The setting was the same as in real surgery. Operations were performed by
experienced retinal surgeons using a surgical microscope. Removal of the lens was done
by phacoemulsification and removal of the vitreous by vitrectomy using a 20 gauge 3
port approach. Visualization was achieved with endoillumination and a 130° contact
lens placed on the corneal surface. Insertion of the device was done either by a scleral
incision or by corneal incisions of 6 mm. Insertion of the device was facilitated by using
a plastic nozzle.
In Vitro test on stimulation and recording capabilities
Healthy Wistar rats were dark adapted for one hour and decapitated in deep anaesthe-
sia. Retinas were taken from the eye under dim red light. The electrodes of the VLARS
MEA were connected to a multichannel recording and stimulating device (MEA2100-
System, Multi Channel Systems GmbH, Reutlingen, Germany). The isolated retina was
placed onto the VLARS MEA with the ganglion cell side adjacent to the electrodes.
The retina was permanently superfused for at least 45 minutes with Carbogene (95%
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trical stimulation a biphasic 40 μA current pulse with a cathodal and anodal phase dur-
ation of 500 μs was chosen. Light stimulation was done using a 1 second white light
flash. The stimulation and recording was done with the MEA-Software MC_Rack
(Multi Channel Systems GmbH, Reutlingen, Germany). For spike detection raw data
sets of 3-5 minutes continuous recording were analyzed with a 300 Hz high-pass filter
and a 3000 Hz low-pass filter and an amplification gain factor of two. The data sam-
pling rate was 25 kHz/channel. To distinguish spike waveforms on one electrode spikes
were sorted computer based and manually with spike sorting software Offline
SorterTM (Plexon Inc, Dallas, Tx, USA) before response analysis was done (Neuro-
ExplorerTM, Nex Technologies, Madison, AL, USA).
All animal experiments were done in accordance with the ARVO statement for the
use of animals in ophthalmic and visual research [http://www.arvo.org/About_ARVO/
Policies/Statement_for_the_Use_of_Animals_in_Ophthalmic_and_Visual_Research/] and




The VLARS stimulation array is based on the fabrication process of the EPI-RET III
implant, which uses the epiretinal concept, i.e. the electrode array is placed on the
inner surface of the retina [16]. During implantation the device must be inserted into
the eyeball through a small corneal incision. After removal of the lens and of the vitre-
ous body the device can be pushed through the anterior chamber into the vitreous
chamber of the eye. From this position it can be further moved to the retinal surface
where it can be placed onto the posterior pole. Stable fixation is provided with a retinal
tack. We designed a VLARS stimulator with a diameter of 12 mm covering an area of
about 110 mm2. A retinal stimulator of that size covers a visual angle of 37.6° in an eye
of normal size (axial length 22.8 mm) representing a visual field of 18.8°. With our
technology, more than 250 electrodes can be realized on such a base structure for a
larger field of percepts and to improve the spatial resolution in the center of the device
compared to current available epiretinal technology.
Design
Shapes for the flexible base structure of the electrode array were identified which can
be easily bent without damage. A foldable design is required to avoid large incisions
for implantation during surgery. This may reduce the corneal incision size down to 5-
6 millimeters. The second critical design parameter is the ability of the structure to fit
to the three-dimensional curved shape of the retina. Because the implant is fabricated
on the wafer level with planar processes it has a completely flat profile, while the retina
is curved. For successful stimulation the device needs to be stretched or compressed
to bring the electrodes in contact with the retina over the whole area. In Figure 2 re-
sults of a numerical simulation using FEM on the mechanical behavior of a polyimide
foil placed in a curved shell are shown. In the cross-section it is obvious and expected
that parts of the implant are not in contact with the retina due to absence of stress-
relieving patterns. At the centre the foil is pressed down and in full contact with the
Figure 2 Simulation of the behaviour of a polyimide foil placed in a spherical shell. Displayed is a
sectional drawing of the model with the von Mises stress of the PI-foil in MPa. Schreibweise: behavior/
behavior (s. Text)
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curvature and eventually lifts up from the tissue. These issues can be addressed in two
ways. The first method would be to create concentric segments within the structure. This
would however make the handling of the structure more difficult during implantation.
The other possibility is to create the devices with an inherent curvature. This could be
done by utilizing the thermal and mechanical properties of the Parylene coating. As our
primary concern is the handling of the stimulator during implantation we chose the
second method.
Material selection
We integrated the MEA into the polyimide PI2611 (HD MicrosystemsTM GmbH,
Neu-Isenburg, Germany) foil. The advantage of this material is its relatively low mois-
ture uptake of 0.5%, which helps to prolong the durability of the system embedded
metallization layers in the prevailing wet conditions. Furthermore polyimide is charac-
terized by a low relative dielectric constant of about 2.9, which also provides an excel-
lent electric isolation of the feed lines of the electrodes. The low intrinsic stress of
PI2611 makes it suitable as a base material for stimulators as the intended one. Add-
itionally, polyimide can be easily structured via photolithographic techniques as it is
soluble in the developer of standard photoresists. The Parylene C encapsulation serves
as an additional moisture barrier due to its hydrophobic behavior. Additionally Parylene
C is moldable under the influence of elevated temperatures. This opens the possibility
of creating curved structures [17].
The 250 electrodes of the final VLARS prototypes are circular shaped with a diameter
of 100 μm. 25 of the electrodes were connected to an external plug connector for
stimulation and recording purposes. The impedance spectra of the electrodes of three
devices are shown in Figure 3. At 1 kHz, a common stimulation frequency, the average
impedance varies around 2 kΩ for all devices. The standard deviation is around 500Ω.
Figure 4 shows a cyclovoltametric (CV) measurement of the iridium oxide electrodes.
It was carried out in a voltage range of -0.8 V to 0.9 V with a ramp speed of 100 mV/s.
The calculated charge delivery capacities of the VLARS electrodes are in the range of
40 to 50 mC/cm2, which is consistent with the literature [18].
Figure 3 Impedance spectra from electrodes of three VLARS devices. Each of the colored lines show
the average of all 25 electrodes of one device. The grey areas represent the standard deviation.
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Figure 5 shows the different designs of the first generation that were tested in enucle-
ated porcine eyes. A continuous, circular shape (D1) served as control. A spiral shape
(D2) was constructed because we thought that it could be easily inserted by turning the
device arms through a small sclerotomy. Moreover, slits between the spiral windings
would have allowed a better fitting to the surface profile of the retina. However, im-
plantation revealed remarkable problems of handling and placing the soft implant ontoFigure 4 Typical cyclovoltametry measurement of VLARS electrodes.
Figure 5 Designs of the first generation of VLARS-prototypes showing the designs D1 (a), D2 (b),
D3 (c) and D4 (d).
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terial damage during implantation.
The star-like shape (D3) was designed because of its theoretical very good unfolding po-
tential. During insertion (surgery) the arms were properly (nicely) bent back and regained
their original shape inside the eye without damage of the device structure. Also it fits well
to the curvature of the eyeball. The globe design (D4) is based on the principle of an inter-
rupted cylindrical projection of a spherical structure on a flat surface.
All first generation designs D1-4 had a central hole for tack fixation. Additional holes
were provided in the periphery of the structure to be used if necessary to support the
primary fixation and keep the electrodes in contact with the retina.
Following first implantation experiments in porcine eyes the prototypes D3 and D4
were selected for further development. Both designs were modified in a way that the ef-
fective area was enlarged by reducing the gaps between the blades and by increasing
their number as shown in Figure 6. The symmetry of the patterns is abandoned to pro-
vide the highest density of electrodes in the center of the structure for stimulation of
the foveal region whereas in the more peripheral areas the electrode density is less cor-
responding to the lower density of ganglion cells and the lower spatial resolution pro-
vided by these retinal areas. The tack fixation site was moved from the center to a
distant position opposite to the optic nerve head to reduce the effect of tissue reaction
at the tack on the stimulation process.Figure 6 Last design revisions that are going to be used for the functional devices. Left, globe
design. Right, star design. In both designs electrodes are arranged in two functional zones, a high density
area intended to be placed at the fovea and a low density zone for contacting more peripheral parts of
the retina.
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Implantation tests in enucleated eyes of pigs and rabbits demonstrated that a transscle-
ral approach to insert these devices may cause a phase of severe hypotony even if the
eye was filled with perfluorocarbon liquids (PFCLs) and even if a PFCL filled nozzle
was used as an insertion aid. Insertion was easier and better controlled if the stimulator
was positioned through a corneal incision as seen in Figure 7. It was also evident, that
the D3 and D4 designs were much more suitable in terms of smooth folding and
unfolding. Both devices could be fixated onto the retinal surface using a single retinal
tack (Figure 7, right panel). The surgeon rated the procedure as complex but feasible
and safe. This rating does not differ from ratings of implantation of clinically available
retinal implants such as the ARGUS II device.
We measured the ohmic resistance between the contact pads and the respective elec-
trodes before and after an implantation experiment to verify, that no damage was done
to the electric wiring. Figure 8 shows no significant change in the ohmic resistance on
any of the electrodes.
Preliminary test on recording capabilities
The VLARS MEA was connected to the MEA2100-Setup as shown in Figure 9.
On the region with the highest electrode density (foveal region), a piece of Wistar
wild-type retina was placed with the ganglion cell layer facing the electrodes. For a
preliminary assessment of stimulation and recording properties of the VLARS MEA
a biphasic current pulse was delivered at one electrode. The stimulation artefact re-
corded from an adjacent electrode was clearly visible but also a neural response with
increased spike activity after the pulse as shown in Figures 10 and 11. In Figure 11
every spike is indicated as a black bar and every row shows one trial. The perievent
histogram (Figure 11, lower traces) summarizes the data of the individual stimulation
trials.
In addition to the studies of the electrical stimulation properties, the recording char-
acteristics of the device were examined in further experiments. Figure 12 (upper trace)
demonstrates that spontaneous firing activity of a retinal ganglion cells could be recorded
with spikes clearly detectable. In further experiments, the retina was illuminated for 1 sec-
ond with a white light flash. The response to the light pulse could be monitored at several
electrodes as an increased firing activity of the displayed ganglion cell (Figure 12, lower
trace). The apparent action potentials were sorted and analyzed. Figure 13 (upperFigure 7 Left: VLARS MEA with star design before implantation into the pig eye. Center: Insertion of
the VLARS MEA into the implantation nozzle. Right: Globe type MEA placed onto the retinal surface of a pig
eye and fixated with a retinal tack.
Figure 9 Functional testing of a star type VLARS MEA. For recording of spontaneous and evoked spike
activity a piece of the retina (arrow) from a Wistar rat was placed with the ganglion cell layer onto the
VLARS-MEA. The bond pads on the right are connected to the MEA hardware equipment for recording and
stimulation. The wires connect each of 25 active VLARS electrodes with the bond pads.
Figure 8 Measurements of the ohmic resistance of the contacted electrodes before and after
implantation shows no signs of damage by the implantation experiment.
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Figure 10 Monitoring of neural activity after stimulation in the isolated rat retina using a VLARS
MEA. Arrowhead shows the stimulation artifact of the biphasic current pulse. The neural response could be
detected as evoked spikes marked with an arrow.
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Every spike is figured as a black bar and every row shows one trial. Illumination started
at time-point 0. The time range from -0.5 s to 0 s indicates the spontaneous firing ac-
tivity of the neuron under red light. The perievent histogram (Figure 13, lower traces)
summarizes the data of the individual light trials. After about 80 ms an increase of the
spiking activity could be recorded as a response to the light stimulus. With the VLARS
MEA it was possible to monitor light responses at seven of the nine connected foveal
electrodes.Figure 11 Perievent raster with histogram of 10 trials. The response of a wild type Wistar rat retinal
ganglion cell to a biphasic current pulse recorded with a VLARS MEA. The pulse started at time point “0”
(black triangle). The perievent histrogram (lower trace) summarizes the results of the corresponding
perievent raster (upper traces). The neural response could be detected immediately after stimulation. Bin
size 5 ms.
Figure 12 Monitoring of neural activity in the isolated rat retina using a VLARS MEA. Top,
spontaneous spiking activity of retinal ganglion cells. Bottom, ganglion cell response to light stimulation.
Representative recording from one of the connected electrodes.
Figure 13 Perievent raster with histogram of four trials. The response of a wild type Wistar rat retinal
ganglion cell to a one second white light flash recorded with a VLARS MEA. The illumination started at time
point “0” (black triangle). The graph shows spontaneous activity 500 ms before stimulus onset, the response
during the one second light stimulus and the activity 500 ms after illumination. Bin size 5 ms.
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Stimulators covering a large area of the retinal surface needed to be fitted to the retinal
surface topography. The inner surface of the eye is different from an ideal spherical
curvature and moreover due to different axial sizes of eyes the inner curvature also dif-
fers within individuals. Despite the fact that, individually designed and fabricated stimu-
lators would be great to ensure a perfect fit with the individual surface topography, but
the first step in the development of large arrays is the fabrication of a general design
which fits for many sizes of eyes as a proof of concept device. Larger variations are
considerably increasing the complexity of the fabrication process and are currently not
regarded as useful since e.g. very small eyes such as in young children are not consid-
ered to be implanted with retinal implants. Implant structures specially designed for
animal experiments covering an extreme variety of eye sizes from mouse to pigs were
not planned to be fabricated within this project.
In the foveal region the image size on the retina is nearly proportional to the visual
angle. An image covering three millimeters in length on the retina corresponds to a visual
angle of approximately 10 degrees [19]. Moreover, it has been shown that there is a strong
correlation between the position of the stimulating electrode on the retinal surface and
the response within the visual cortex and the visual field, respectively [20,21].
Retinal stimulator MEAs can be placed either underneath the retina as subretinal de-
vices or onto the retinal surface as epiretinal devices [7–10]. Both approaches have in
common that current prototypes are designed for stimulation of the foveal region
which may allow a visual angle of about 10° – 18° or 5° – 9° of visual field, respectively.
The VLARS project was started to develop a stimulator MEA covering a larger visual
field. We built a device with a diameter of 12 millimeters covering a retinal area of
about 110 mm2. A retinal stimulator of that size could restore a visual field of about
18.8° covering a corresponding visual angle of 37.6° when implanted in a human eye of
normal size. Additionally, more than 250 electrodes can be placed on such a device
with current available technology.
Large stimulators were also suggested by Villalobos et al. and the Bionic Vision
Australia Group: They described a MEA which can be placed in the suprachoroidal
space with dimensions of 8 × 13 mm, providing a visual angle in the human eye of
about 27.14 × 39.8° or a visual field of 13.6 × 19.9°. MEA systems not in direct contact
with the retina seemed to be limited in terms of spatial resolution because of the dis-
tance between the active electrodes and the target neurons. The advantage of supra-
choroidal implants however might be the low risk profile of the surgery [22,23].
Studies on the safety of the EPIRET III device, which was also based on polyimide
and contained similar materials and the same encapsulation as the VLARS prototypes
confirmed a good biocompatibility and function of the implants [24–27]. For epiretinal
fixation of the device retinal tacks have been shown to provide direct contact of the
electrode array to the retinal surface-a prerequisite for successful retinal ganglion cell
stimulation (re-detected and re-established) [28–30]. While the fixation of small stimu-
lators requires up to two retinal tacks [7,8] it requires further experiments to determine
if larger devices will need more elements for fixation. For this reason our next step will
be the implantation in animal experiments to prove the biocompatibility of the device
and during follow-up examinations to quantify the number of necessary tacks. As op-
tical coherence tomography (OCT) has been successfully used to demonstrate the
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ure will be used for the upcoming experiments. Moreover, stimulating tests will be per-
formed to determine and to evaluate stimulation thresholds of different electrodes in
regard to the retinal contact of each part of the stimulator. Alternative approaches to
avoid mechanical fixation tools have been described in animal experiments but were
not used clinically: Thermosensitive glues and biochemical adhesion provided by
immobilized peptide chains have been used in experimental settings [32,33]. In the fu-
ture these approaches may help to reduce the amount of retinal tacks for fixation of
large epiretinal stimulators.
The main concern for large stimulators is the possibility of intra- or postoperative
complications. The larger incision necessary to implant such devices into an eye could
cause a higher risk of infection, high astigmatism, leakage, and proliferative tissue reac-
tions. Therefore, a flexible device is desirable which can be inserted through a smaller
incision. Our experiments on enucleated pig and rabbit eyes showed that when using a
nozzle the folded device could be inserted through an incision of 5-6 mm, which seems
to be reasonable in terms of risk profile. Stimulation tests and impedance measure-
ments on implanted devices are necessary to demonstrate that stimulators endure the
implantation without any damage.
Currently available epiretinal implants have certain drawbacks not only concerning
their stimulator size but also concerning electrode size and material, and stimulation al-
gorithms. To yield better spatial resolution a higher density of electrodes is desirable al-
though that usually means to design smaller electrodes with a greater risk of adverse
electrochemical reactions at their surface. Such electrochemical reactions have to be
avoided by proper selection of the electrode surface material. Stimulation algorithms
usually do not take into account that not only ganglion cells may be stimulated but also
other excitable cells like amacrine cells or even bipolar cells [34]. The activation of pos-
sibly inhibiting local neural networks in the degenerated retina may prevent useful gan-
glion cell activity. Furthermore, high current or voltage stimulation could evoke action
potentials in axons whose somatas are far away from the stimulation site. This may in-
duce percepts coming from a retinal region unrelated to the position of the electrode
[35,36]. These factors have to be taken also into account when future implant concepts
are discussed. However, the enlargement of the stimulator area may be one step
towards a larger visual field in otherwise blind subjects.
We were able to demonstrate in a preliminary experiment, that the device is useful for
electrical stimulation of the retina and that it also has the potential to record neural net-
work activity. The latter allows the realization of bidirectional implants capable to record
from the target tissue and to stimulate the tissue. The recordings could probably be used
to automatically modify and optimize the stimulation pattern, which is usually based on
image characteristics and fixed assumptions on the functional state of the retina.
Conclusions
The successful fabrication of VLARS prototypes and the promising observations concern-
ing surgical handling, stimulation and recording represent first steps in the realization of a
large stimulating array for wide-field direct epiretinal stimulation to generate artificial
vision with enlarged visual fields. Further experiments are necessary to demonstrate its
long-term biocompatibility in-vivo and also its stimulation properties.
Waschkowski et al. BioMedical Engineering OnLine 2014, 13:11 Page 14 of 15
http://www.biomedical-engineering-online.com/content/13/1/11Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
FW performed the CAD design of the prototypes and simulated the mechanical properties of the VLARS MEAs and
fabricated the prototypes under the supervision of WM. He wrote significant parts of the manuscript. SH did the
recording and stimulation experiments with the VLARS MEAs and wrote the specific parts of the manuscript. ACR
and TL prepared the surgical experiments and were responsible for the documentation. They did the literature search.
CB and TLaube assisted in the surgical experiments and contributed extensively to the design concepts discussion and
handling evaluation. NB, WM, GT, SJ, and PW developed the concept of VLARS MEAs, wrote the grant application, and
wrote significant parts of the manuscript. They finally approved the paper. GR and GT performed the surgical handling
tests and wrote the corresponding sections of the manuscript. All authors read and approved the final manuscript.
Acknowledgment
This work was supported by a grant of the Jackstädt Foundation “VLARS”.
SH was supported by DFG grants WA 1472/6-1, TH 603/15-1, MU 3036/3-1.
Author details
1Institute for Materials in Electrical Engineering I, RWTH Aachen University, Sommerfeldstr 24, 52074 Aachen, Germany.
2Department of Ophthalmology, University Hospital Aachen, RWTH Aachen University, Pauwelsstr 30, 52074 Aachen,
Germany. 3Department of Ophthalmology, University Hospital Essen, Hufelandstr 55, 45147 Essen, Germany. 4Hôpitaux
universitaires de Genève, Service d’ophtalmologie, Rue Alcide-Jentzer 22, CH-1211 Genève 14, Suisse.
Received: 20 August 2013 Accepted: 29 January 2014
Published: 6 February 2014
References
1. Daiger SP, Bowne SJ, Sullivan LS: Perspective on genes and mutations causing retinitis pigmentosa. Arch
Ophthalmol 2007, 125:151–158.
2. Aldahmesh MA, Abu Safieh L, Alkuraya H, Al-Rajhi A, Shamseldin H, Hashem M, Alzahrani F, Khan AO, Alqahtani F,
Rahbeeni Z, Alowain M, Khalak H, Al-Hazzaa S, Meyer BF, Alkuraya FS: Molecular characterization of retinitis
pigmentosa in Saudi Arabia. Mol Vis 2009, 15:2464–2469.
3. Bunker CH, Berson EL, Bromley WC, Hayes RP, Roderick TH: Prevalence of retinitis pigmentosa in Maine. Am J
Ophthalmol 1984, 97:357–365.
4. Humayun MS, de Juan E, Dagnelie G Jr, Greenberg RJ, Propst RH, Philips DH: Visual perception elicited by
electrical stimulation of retina in blind humans. Arch Ophthalmol 1996, 114:40–46.
5. Hornig R, Laube T, Walter P, Velikay-Parel M, Bornfeld N, Feucht M, Akguel H, Rössler G, Alteheld N, Lütke Notarp
B, Wyatt J, Richard G: A method and technical equipment for an acute human trial to evaluate retinal implant
technology. J Neural Eng 2005, 2:129–134.
6. Keserü M, Feucht M, Bornfeld N, Laube T, Walter P, Rössler G, Velikay-Parel M, Hornig R, Richard G: Acute electrical
stimulation of the human retina with an epiretinal electrode array. Acta Ophthalmol 2012, 90:e1–e8.
7. Yanai D, Weiland JD, Mahadevappa M, Greenberg RJ, Fine I, Humayun MS: Visual performance using a retinal
prosthesis in three subjects with retinitis pigmentosa. Am J Ophthalmol 2007, 143:820–827.
8. Roessler G, Laube T, Brockmann C, Kirschkamp T, Mazinani B, Goertz M, Koch C, Krisch I, Sellhaus B, Trieu HK, Weis
J, Bornfeld N Rothgen H, Messner A, Mokwa W, Walter P: Implantation and explantation of a wireless epiretinal
retina implant device: observations during the EPIRET3 prospective clinical trial. Invest Ophthalmol Vis Sci 2009,
50:3003–3008.
9. Benav H, Bartz-Schmidt KU, Besch D, Bruckmann A, Gekeler F, Greppmaier U, Harscher A, Kibbel S, Kusnyerik A,
Peters T, Sachs H, Stett A, Stingl K, Wilhelm B, Wilke R, Wrobel W, Zrenner E: Restoration of useful vision up to
letter recognition capabilities using subretinal microphotodiodes. Conf Proc IEEE Eng Med Biol Soc 2010,
1:5919–5922.
10. Menzel-Severing J, Laube T, Brockmann C, Bornfeld N, Mokwa W, Mazinani B, Walter P, Roessler G: Implantation
and explantation of an active epiretinal visual prosthesis: 2-year follow-up data from the EPIRET3 prospective
clinical trial. Eye (Lond) 2012, 26(4):501–509.
11. Eckmiller R: Learning retina implants with epiretinal contacts. Ophthalmic Res 1997, 29:281–289.
12. Stieglitz T, Beutel H, Keller R, Blau C, Meyer JU: Development of flexible stimulation devices for a retina implant
system. Conf Proc IEEE Eng Med Biol Soc 1997, 5:2307–2310.
13. Mokwa W, Goertz M, Koch C, Krisch I, Trieu HK, Walter P: Intraocular epiretinal prosthesis to restore vision in
blind humans. Conf Proc IEEE Eng Med Biol Soc 2008, 1-8:5790–5793.
14. Patel KS, Kohl PA, Bidstrup Allen SA: Dual capacitor technique for measurement of through-plane modulus of
thin polymer films. J Polym Sci B 2000, 38(12):1634–1644.
15. Koch C, Fassbender H, Nolten U, Goertz M, Mokwa W: Fabrication and assembly techniques for a 3rd generation
wireless epiretinal prosthesis. Aachen, Germany: Proc. of MME 2008, 19th Workshop on Micromachining,
Micromechanics and Microsystems; 2008:365–368. ISBN: 978-3-00-025529-8.
16. Mokwa W, Görtz M, Koch C, Krisch I, Trieu HK, Walter P: Intraocular epiretinal Prothesis to restore vision in blind
humans. In Proc. of the 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society,
Vancouver. Piscataway, NJ, USA: EMBS; 2008:5790–5793.
17. Rodger DC, Fong AJ, Li W, Ameri H, Ahuja AK, Gutierrez C, Lavrov I, Zhong H, Menon PR, Meng E, Burdick JW, Roy
RR, Edgerton VR, Weiland JD, Humayun MS, Tai YC: Flexible parylene-based multielectrode array technology for
high-density neural stimulation and recording. Sens Actuators B 2008, 132(2):449–460. ISSN 0925-4005, http://dx.
doi.org/10.1016/j.snb.2007.10.069.
Waschkowski et al. BioMedical Engineering OnLine 2014, 13:11 Page 15 of 15
http://www.biomedical-engineering-online.com/content/13/1/1118. Wessling B, Mokwa W, Schnakenberg U: RF-sputtering of iridium oxide to be used as stimulation material in
functional medical implants. J Micromech Microeng 2006, 16(6):S142–S148.
19. Drasdo N, Fowler CW: Non-linear projection of the retinal image in a wide-angle schematic eye. Br J
Ophthalmol 1974, 58:709.
20. Eckhorn R, Wilms M, Schanze T, Eger M, Hesse L, Eysel UT, Kisvarday ZF, Zrenner E, Gekeler F, Schwahn H, Shinoda
K, Sachs H, Walter P: Visual resolution with retinal implants estimated from recordings in cat visual cortex.
Vision Res 2006, 46(17):2675–2690.
21. Walter P, Kisvárday ZF, Görtz M, Alteheld N, Rossler G, Stieglitz T, Eysel UT: Cortical activation via an implanted
wireless retinal prosthesis. Invest Ophthalmol Vis Sci 2005, 46(5):1780–1785.
22. Ameri H, Ratanapakorn T, Ufer S, Eekhardt H, Humayun MS, Weiland JD: Toward wide-field retinal prosthesis.
J Neural Eng 2009, 1:6(3).
23. Villalobos J, Allen PJ, McCombe MF, Ulaganathan M, Zamir E, Ng DC, Shepherd RK, Williams CE: Development of
a surgical approach for a wide-view suprachoroida retinal prosthesis: evaluation of implantation trauma.
Graefes Arch Clin Exp Ophthalmol 2012, 250:399–407.
24. Klauke S, Goertz M, Rein S, Hoehl D, Thomas U, Eckhorn R, Bremmer F, Wachtler T: Stimulation with a wireless
intraocular epiretinal implant elicits visual percepts in blind humans. Invest Ophthalmol Vis Sci 2011,
52:449–455.
25. Walter P, Szurman P, Vobig M, Berk H, Ludtke-Handjery HC, Richter H, Mittermayer C, Heimann K, Sellhaus B:
Successful long-term implantation of electrically inactive epiretinal microelectrode arrays in rabbits. Retina
1999, 19:546–552.
26. Menzel-Severing J, Sellhaus B, Laube T, Brockmann C, Bornfeld N, Walter P, Roessler G: Surgical results and
microscopic analysis of the tissue reaction following implantation and explantation of an intraocular implant
for epiretinal stimulation in minipigs. Ophthalmic Res 2011, 46:192–198.
27. Laube T, Brockmann C, Roessler G, Walter P, Krueger C, Goertz M, Klauke S, Bornfeld N: Development of surgical
techniques for implantation of a wireless intraocular epiretinal retina implant in Göttingen minipigs. Graefes
Arch Clin Exp Ophthalmol 2012, 250:51–59.
28. Ando F, Kondo J: A plastic tack for the treatment of retinal detachment with giant tear. Am J Ophthalmol 1983,
95:260–261.
29. de Juan E, Machemer R: Retinal tacks. Am J Ophthalmol 1985, 99:272–274.
30. Majji AB, Humayun MS, Weiland JD, Suzuki S, D’Anna SA, de Juan E Jr: Long-term histological and electrophysiological
results of an inactive epiretinal electrode array implantation in dogs. Invest Ophthalmol Vis Sci 1999, 40:2073–2081.
31. Ahuja AK, Yeoh J, Dorn JD, Caspi A, Wuyyuru V, McMahon MJ, Humayun MS, Greenberg RJ, Dacruz L: Factors affecting
perceptual threshold in Argus II retinal prosthesis subjects. Transl Vis Sci Technol 2013, 2(4):1. Epub 2013 Apr 12.
32. Roessler G, Klee D, Mokwa W, Alteheld N, Harwardt M, Koch C, Hungar K, Sellhaus B, Walter P: Development of
biochemically modified inactive retinal implants for fixation testing in animal experiments [abstract]. Invest
Ophthalmol Vis Sci 2006, 47:3175. ARVO E-Abstract.
33. Tunc M, Humayun M, Xuanghong C, Ratner BD: A reversible thermosensitive adhesive for retinal implants.
Retina 2008, 28:1338–1343.
34. Margalit E, Babai N, Luo J, Thoreson WB: Inner and outer retinal mechanisms engaged by epiretinal stimulation
in normal and rd mice. Vis Neurosci 2011, 28:145–154.
35. Fried SI, Lasker ACW, Desai NJ, Eddington DK, Rizzo JF: Axonal sodium-channel bands shape the response to
electric stimulation in retinal ganglion cells. J Neurophysiol 2009, 101:1972–1987.
36. Jensen RJ, Rizzo JF, Ziv R, Grumet A, Wyatt J: Thresholds for activation of rabbit retinal ganglion cells with an
ultrafine, extracellular microelectrode. Invest Ophthalmol Vis Sci 2003, 44:3533–3543.doi:10.1186/1475-925X-13-11
Cite this article as: Waschkowski et al.: Development of very large electrode arrays for epiretinal stimulation
(VLARS). BioMedical Engineering OnLine 2014 13:11.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
